Sustained quality-of-life improvement post-cryoballoon ablation in patients with paroxysmal atrial fibrillation: results from the STOP-AF Post-Approval Study

SK Jain, PG Novak, R Sangrigoli, J Champagne… - Heart rhythm, 2020 - Elsevier
Background Pulmonary vein isolation by catheter ablation is a class IA indication for the
treatment of symptomatic, drug-refractory, paroxysmal atrial fibrillation (PAF). Quality of life …

Effectiveness of percutaneous coronary intervention within 12 hours to 28 days of ST-elevation myocardial infarction in a real-world Chinese population

X Wu, D Yang, Y Zhao, C Lu, Y Wang - PloS one, 2013 - journals.plos.org
Objectives Percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction
(STEMI) has been widely accepted for patient who come within 12 hours, but for those who …

Percutaneous coronary intervention versus optimal medical therapy for stable angina in advanced CKD: a decision analysis

A Khattak, EI Mandel, MR Reynolds… - American Journal of …, 2017 - Elsevier
Background Percutaneous coronary intervention (PCI) use is low in the setting of stable
symptomatic angina in individuals with advanced chronic kidney disease (CKD) despite …

Towards evidence-based percutaneous coronary intervention: the René Laënnec lecture in clinical cardiology

PA Calvert, PG Steg - European heart journal, 2012 - academic.oup.com
Percutaneous coronary intervention (PCI) has matured from a pioneering adventure focused
on feasibility to a major sub-specialty delivering real clinical results to patients. Despite …

Percutaneous Coronary Intervention versus Optimal Medical Therapy on Quality of Life and Functional Capacity Assessment in Chronic Coronary Syndrome: A Meta …

S Ibrahim, SM Allihien, B Addo, AF Osman… - medRxiv, 2024 - medrxiv.org
Background: Previous studies have primarily examined the impact of percutaneous coronary
intervention (PCI) compared to optimal medical therapy (OMT) on hard outcomes such as all …

[PDF][PDF] Chronische KHK

N VersorgungsLeitlinie - Langfassung Version, 2013 - leitlinien.de
Bitte beachten Sie, dass nur die unter www. leitlinien. de enthaltenen Dokumente des
Programms für Nationale Versorgungs-Leitlinien durch die Träger des NVL-Programms …

What matters most to patients following percutaneous coronary interventions? A new patient-reported outcome measure developed using Rasch analysis

SE Soh, AL Barker, DR Ayton, S Ahern, R Morello… - Plos One, 2019 - journals.plos.org
Introduction Measuring patient reported outcomes can improve the quality and effectiveness
of healthcare interventions. The aim of this study was to identify the final set of items that can …

Atheroma or ischemia: which is more important for managing patients with stable chest pain?

H Bashar, J Hinton, N Curzen - Future Cardiology, 2022 - Taylor & Francis
In the evaluation and management of patients with stable chest pain/chronic coronary
syndrome, cardiologists need to be able to weigh up the relative merits of managing these …

Appropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decision

S Akil, F Hedeer, J Oddstig, T Olsson, J Jögi… - Journal of Nuclear …, 2021 - Elsevier
Background Many patients undergo percutaneous coronary intervention (PCI) without the
use of non-invasive stress testing prior to treatment. The aim of this study was to determine …

Diagnostic implications in the aftermath of the ISCHEMIA trial

GBJ Mancini, WE Boden - The American Journal of Cardiology, 2020 - Elsevier
The recently reported ISCHEMIA trial will reignite the debate regarding the optimal first
diagnostic test when evaluating chest pain in patients suspected to have coronary artery …